The second wave in kinase cancer drugs (Q82498098)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 February 2006

edit

Language	Label	Description	Also known as
English	The second wave in kinase cancer drugs	scientific article published on 01 February 2006

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

title

The second wave in kinase cancer drugs (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

author name string

Ken Garber

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

publication date

1 February 2006

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

published in

Nature Biotechnology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

volume

24

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

page(s)

127-130

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

cites work

Strategies to overcome resistance to targeted protein kinase inhibitors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for the design of potent and selective kinase inhibitors.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Multi-kinase inhibitors create buzz at ASCO.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The protein kinase complement of the human genome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Tyrosine kinases as targets for cancer therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0206-127

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/NBT0206-127

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

PubMed publication ID

16465146

1 reference

stated in

Europe PubMed Central

PubMed publication ID

16465146

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16465146%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82498098&oldid=2221255382"